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Abstract:  Following  contamination  from  the  Chernobyl  accident  in  April  1986 excess 
infant  leukemia  (0–1  y)  was  reported  from  five  different  countries,  Scotland,  Greece, 
Germany, Belarus and Wales and Scotland combined. The cumulative absorbed doses to 
the fetus, as conventionally assessed, varied from 0.02 mSv in the UK through 0.06 mSv in 
Germany, 0.2 mSv in Greece and 2 mSv in Belarus, where it was highest. Nevertheless, the 
effect was real and given the specificity of the cohort raised questions about the safety of 
applying the current radiation risk model of the International Commission on Radiological 
Protection (ICRP) to these internal exposures, a matter which was discussed in 2000 by 
Busby and Cato [7,8] and also in the reports of the UK Committee examining Radiation 
Risk from Internal Emitters. Data on infant leukemia in the United Kingdom, chosen on the 
basis of the cohorts defined by the study of Greece were supplied by the UK Childhood 
Cancer Research Group. This  has  enabled a study of  leukemia  in  the combined infant 
population of 15,466,845 born in the UK, Greece, and Germany between 1980 and 1990. 
Results show a statistically significant excess risk RR = 1.43 (95% CI 1.13 < RR < 1.80  
(2-tailed); p = 0.0025) in those born during the defined peak exposure period of 01/07/86 to 
31/12/87  compared  with  those  born  between  01/01/80  and  31/12/85  and  01/01/88  
and 31/12/90. The excess risks in individual countries do not increase monotonically with 
the conventionally calculated doses, the relation being biphasic, increasing sharply at low 
doses and falling at high doses. This result is discussed in relation to fetal/cell death at 
higher doses and also to induction of DNA repair. Since the cohort is chosen specifically 
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on the basis of exposure to internal radionuclides, the result can be expressed as evidence 
for a significant error in the conventional modeling for such internal fetal exposures. 
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1. Introduction  
 
The Chernobyl accident contaminated most of Europe with fission-product radioisotopes including 
short-lived, high-activity Iodine and Tellurium, and also fuel particles containing uranium and other 
intermediate half-life isotopes, including the 30-year half life Caesium-137 [1]. In the UK, whole body 
monitoring showed the persistence of Caesium-137 in the population [2] and grassland surveys enabled 
the radiological modeling of equivalent dose. In general, the exposures in Europe were examined in 
some detail and doses to the population were well characterized [1]. For all of the countries of Europe 
except  Belarus,  the  first  year  average  committed  effective  doses  were  below  1  mSv,  ranging  from  
0.02 mSv for the whole of the UK through 0.07 mSv for the whole of Germany, 0.2 mSv for Greece up 
to 2 mSv for Belarus. At these levels, the risk model of the International Commission on Radiological 
Protection (ICRP) predicts no measurable health effects. The absorbed doses were less than a quarter 
the mean natural background dose, and if dose has any universal radiological meaning, the exposures 
must be considered safe. Nevertheless there were reported increases in infant leukemia in the in utero 
exposed  cohort  in  Scotland  [3],  Belarus  [4]  Greece  [5],  Germany  [6]  and  Wales  and  Scotland 
combined [7,8].  
Busby and Scott Cato [7,8] examined the likely absorbed doses to the children and applied the 
current  radiation  risk  models  of  the  ICRP,  those  employed  also  by  all  radiological  protection 
legislation, to show that the risk factors currently being employed for the protection of members of the 
public were in error by upwards of 100-fold. Such an error might begin to illuminate other apparently 
inexplicable associations between childhood leukemia and exposure near nuclear sites, notably the 
ongoing child leukemia cluster near the UK Sellafield reprocessing plant in Cumbria [9] and the results 
of the recent KiKK study in Germany [10]. Infant leukemia is believed to be a consequence of a gene 
mutation in utero [5]. The importance of the infant leukemia results are that the in utero doses were 
well characterized, and that since the cohort is so well described, there is really no other explanation 
for the finding apart from exposure to ionizing radiation. Thus the existence of the effect may be taken 
as a prima facie evidence of the failure of the ICRP model and may be used to determine the accurate 
risk factors for this kind of internal exposure. 
The  seriousness  of  this  question  led  in  the  UK  to  the  formation  of  the  Committee  Examining 
Radiation Risk from Internal Emitters (CERRIE) whose remit was to examine the assertion that for 
internal exposures from fission–product radioisotopes, the true risk factors for cancer and leukemia 
were much greater than those currently employed by the radiation protection legislation. It was argued 
that the ICRP model was largely based on historical external radiation exposure studies, principally 
that of the Japanese A-bomb survivors and may not be safe for examining internal chronic exposures. 
This question was addressed in 2003 by the new European Committee on Radiation Risk (ECRR) [11] Int. J. Environ. Res. Public Health 2009, 6                 
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and also in 2006 by the French IRSN [12]. The application of the ICRP model (which is based on adult 
exposures) to fetal exposures has also been questioned recently [13,14]. 
As part of its remit to examine the issue, CERRIE applied to the Oxford-based Childhood Cancer 
Research Group (CCRG) in order to follow up the 2000 Busby and Cato analysis [7,8] by examining 
the UK by contamination area and period. Data limitations had forced Busby and Scott Cato to employ 
very slightly different periods to those used by Petridou et al. [5] and Kaletsch et al. [6] and CERRIE 
decided to obtain data for the same periods. The first question was whether there was an effect in the 
high and intermediate exposure areas of the UK if the time periods used by Petridou et al. [5] were 
used to define exposure cohorts. Exposure in the UK depended upon rainfall at the time, and areas 
were agreed on the basis of measurements made by the UK National Radiological Protection Board 
and  supplied  to  CERRIE.  Results  of  the  CERRIE  analysis  were  difficult  to  interpret  since  the 
committee failed to agree on the significance of the data. There were two reports. The main report 
presented a statistically significant excess risk in Greece and Germany and non-statistically significant 
excess risk in the UK and in Belarus but was disinclined to conclude that the effect was real [15]. A 
minority of the committee argued that the effect had occurred in different countries as well as the UK 
and therefore should be taken as evidence that raised questions over the adequacy of the ICRP risk 
model for radiation safety [16].  
 
2. Method 
 
In the present study the populations of Germany, Greece and the UK and the respective population-
weighted doses, are combined into one meta-analysis which is employed to examine the risks of infant 
leukemia from this type of internal exposure compared with the best available external exposure data, 
that  of  the  Oxford  Series  obstetric  X-ray  studies  [17].  Standard  contingency  table  analysis  was 
employed to compare risk in unexposed (periods A + C) with exposed (B) cohorts.  
 
3. Results 
 
Table 1 shows the time periods A, B and C employed by Petridou et al. (1996) [2] and for which the 
CCRG data from the UK was made available. Table 2 gives the number of infant leukemia cases (male 
and  female  combined)  diagnosed  in  the  period  and  the  rates  per  100,000  population  0–1  (birth 
population supplied by CCRG). Table 3 gives the data for all three countries and for all cases in the 
UK and compares the rates per 100,000 births with the mean population weighted fetal doses obtained 
from the original data and also from the UK National Radiological Protection Board which supplied 
the data to CERRIE. 
Table 1. Exposure categories and time periods employed in the present study. 
Cohort Group code  Time period   In utero exposure  
Petridou et al. analysis periods 
A  01/01/80 to 31/12/85  Unexposed 
B  01/07/86 to 31/12/87  Exposed 
C  01/01/88 to 31/12/90  Unexposed Int. J. Environ. Res. Public Health 2009, 6                 
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Table 2. Number of infant leukemia cases (rates per 100,000 births in the period) in UK by 
exposure category (from CCRG).  
Period 
Exposure category 
High  Medium  Low  Total 
A  3 (3.33)  52 (2.2)  66 (3.69)  121 (2.86) 
B  1 (4.32)  16 (2.6)  24 (5.0)  41 (3.69) 
C  2 (4.16)  39 (3.15)  35 (3.5)  76 (3.33) 
Total  6 (3.72)  107 (2.54)  125 (3.8)  238 (3.11) 
Table 3. Infant leukemia in UK Greece and Germany in the Chernobyl in utero exposure 
periods, (with rates per 100,000 and mean population-weighted fetal doses). 
  Mean Dose 
d(mSv) 
Period  A 
unexposed 
Period B 
 Exposed 
Period C  
unexposed 
a UK all cases  0.02  121 (2.86)  41 (3.69)  76 (3.33) 
UK births    4237421  1112069  2282014 
b Germany all cases  0.1  83 (2.30)  35 (3.76)  60 (2.96) 
Germany births    3601176  928649  2029613 
c Greece all cases  0.2  22 (2.75)  12 (7.35)  9 (2.89) 
Greece births    801175  163337  311391 
All 3 all cases  0.067  226 (2.62)  88 (3.99)  145 (3.13) 
All 3 births    8639772  2204055  4623018 
a from CCRG; 
b from Kaletsch et al.; 
c from Petridou et al.; 
d from original data, 
furnished by NRPB for CERRIE. 
 
In the United Kingdom, the fallout from Chernobyl was patchy, and related to outbreaks of thundery 
rain that occurred in Scotland, Wales and Yorkshire. However, food supplies in the UK are sourced 
from all areas and therefore it is not at all clear that the high external exposure areas defined  by 
CERRIE  will  be  the  same  as  high  internal  exposure  areas.  Significant  Cs-137  contamination  was 
measured  by  whole  body  monitoring  at  Oxford  in  the  south  of  the  UK  where  there  was  little 
precipitation both in the Summer of 1986 and the Spring of 1987 [2]. The high exposure area defined 
by NRPB for CERRIE was quite low in population and for this reason the high and intermediate areas 
are combined into one area. Results are given in Table 4. 
Table  4. Statistics of infant leukemia rates in the UK based upon high + intermediate 
exposure groups in Scotland, North Wales and Yorkshire. Comparison of exposed (B) and 
unexposed (A + C) periods after Petridou et al.; data from CCRG. 
Data Period  Cases  
High + Intermediate (rates) 
Population 
High + Intermediate 
A  69 (2.8)  2453548 
B  25 (4.0)  632073 
C  37 (2.9)  12840973 
Statistics. B vs (A + C)  Relative Risk 1.4 (95% C. I. 0.88 < RR < 2.20) 

2 = 2.26; p = 0.132; two tailed 
 Int. J. Environ. Res. Public Health 2009, 6                 
 
 
3109 
Table 5 gives results for all three countries combine comparing the excess risk of infant leukemia in 
the exposed cohort with the unexposed cohorts on the basis of mean exposure doses in utero.  
Table 5. Infant leukemia in the combined population of UK, Germany [3] and Greece [2] 
using all UK data from CCRG. 
Data Period  Cases (rates)  Population 
A  226 (2.62)  8639772 
B  88 (4.0)  2204055 
C  145 (3.1)  4623018 
B vs (A + C)  Relative Risk 1.43 (95% C.I. 1.13 < RR < 1.80) 

2 = 9.1; p = 0.0025; two tailed 
 
4. Discussion 
 
In the UK data, supplied by CCRG, and based upon the 1996 Petridou et al. [5] birth cohort criteria, 
there was an increase in infant leukemia in the exposed cohort in both the high and intermediate group 
combined and also in the total population. Unlike the increases in Scotland and Wales [7,8], the UK 
increase fell short of statistical significance at the p = 0.05 level using a two tailed test though would 
have been statistically significant using a directional test (which is justified since the prior hypothesis is 
directional:  no  one would argue that  exposure  to  radiation  would have  reduced the risk of infant 
leukemia). This result (Table 4) differs from the earlier finding of Busby and Cato for Wales and 
Scotland [7,8] which found a statistically significant excess risk of RR = 3.9; p = 0.0002) because 
different areas were employed by CERRIE and also a slightly different period was employed. Most of 
the  UK  was  unexposed  and  so  the  exposed  population  was  diluted  with  unexposed  individuals, 
reducing the Relative Risk and therefore also the statistical significance. 
Combining the UK increases with those in Greece and Germany, (where the doses were greater) 
gave  a  43%  increase  in  infant  leukemia  in  the  combined  cohort  of  2.2  million  births  in  children 
exposed to a mean population weighted dose of 0.067 mSv. The mean dose was obtained by population 
weighting the fetal doses determined for each country supplied by NRPB to the CERRIE committee for 
UK  and  obtained  from  the  German  study  [6]  where  the  doses  were  measured  by  the  German 
Radiological Protection personnel and from UN data for Greece [1]. It should be emphasized that the 
internal dose here is unknown. The dose calculations are based mainly upon external dose, mainly 
gamma shine from Caesium-137 deposition. However, it is just this (mainly) external dose that is 
employed in radiological modeling of health effects, and so for the purpose of what follows this is the 
dose that is relevant. 
In calculating the dissonance between the predictions of the ICRP models and the observed number 
of cases found in Scotland and Wales, Busby and Cato [7,8] used the ICRP risk factor of 0.0125 per 
Sievert (employed by the UK government COMARE committee in 1996 to examine the Sellafield 
child leukemias) [17]. However, in discussions within CERRIE it was pointed out that the obstetric 
data of Stewart et al. [18] was a firmer basis on which to compare the risks from internal fetal exposure 
with those from external. Stewart et al. found a 40% increase in childhood cancer aged 0-14 after an X-
ray dose of 10mSv [19].  Int. J. Environ. Res. Public Health 2009, 6                 
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If we assume a 10mSv X-ray dose causes a 40% increase in childhood cancer, it is clear from  
Table 5 that a mean dose of 0.067 mSv from Chernobyl fallout has caused a mean increase in infant 
leukemia of 43%. The mean corresponding error in the application of the obstetric external risk factor 
to the infant leukemias is thus 43/40 ×  10/0.067 = 160. There were therefore 160 times more infant 
leukemias in this combined population that would be predicted by the use of the obstetric X-ray data. 
And this is only in children aged 0–1: this is a minimum value, as we have yet to see what other 
cancers or leukemias emerge in this group as they age between 1 and 14 years. If the ICRP cancer risk 
coefficient  is  employed, as  it was  in  the COMARE analysis of the Sellafield child leukemias the 
difference between the observed and predicted number of infant leukemias would be far greater, in 
excess of 1000-fold. 
Because the number of exposed children is so large, it can be safely concluded that there was a real 
increase in infant leukemia in those who were exposed in utero to the fallout from Chernobyl although 
we cannot say for certain that the effect was not due to parental pre-conception irradiation, since our 
exposed groups (defined by Petridou et al.) were born up to the end of 1987.  
A number of researchers have dismissed the increases in infant leukemia following the Chernobyl 
fallout as causally due to radiation exposure on the basis that the dose response relationship does not 
increase monotonically e.g., [6,8]. This argument needs to be addressed. 
In the data available from the several countries, there was also a biological gradient in the rates over 
a certain range. Figure 1 shows the increases in infant leukemia with dose in the European countries 
which have been studied.  
Figure 1. Dose response for infant leukemia in the countries examined by this study and 
CERRIE. (Data from CCRG and CERRIE [15]. Effect is fractional excess risk, and dose is 
in mSv. 
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The German study presented results for three dose areas and showed that the dose response was 
biphasic, i.e., the greatest effect was not at the highest reported dose level. This was also true for the 
data from the UK when it was subdivided into the high, intermediate and low dose areas. In both 
countries the highest effect was in the intermediate dose area. Infant leukemia increases were also 
reported in Belarus [4] and the effect there was quite modest there although the doses were higher than 
in  Greece.  The  data  suggest  that  over  the  range  0–2  mSv  the  overall  dose  response  is  biphasic  
(Figure 1).  
This biphasic behaviour is not remarkable for an in utero cause and endpoints in the living child, 
since  above  a  certain  dose  some  defense  system  may  become  overwhelmed  and  fetal  death  may 
intervene. Increasing the dose of any fetal poison will generally result in fetal damage and ultimately in 
death of the fetus. Therefore the highest doses will not necessarily produce the greatest effect if the 
outcome is measured after birth. Alternatively, biphasic radiation dose response relationships have 
been reported in the literature by Burlakova, who believes they represent a consequence of induced 
repair efficiency and the overwhelming of defense responses [20]. In addition, dismissal of causality 
because of the absence of a monotonic increase in effect with external dose may be insecure since it is 
not clear that the dose levels reported correlate with internal exposures of the specific type that cause 
the illnesses, since agricultural produce from high exposure areas may end up anywhere in the country 
or even in another country. In the main, the exposures used for these studies are based upon external 
radiation measurements or ground deposition of Caesium-137. If the exposures were to milk from 
cattle fed in the winter of 1986/87 with grass contaminated with radionuclides, this milk might end up 
anywhere  in  the  country,  not  necessarily  where  the  main  deposition  was;  indeed  dairy  cattle  are 
unlikely to be feeding in areas where the rainfall is high e.g. mountains. In support of this conclusion it 
is clear from the whole body monitoring results in the South of England, where Cs-137 precipitation 
was almost absent, that winter cattle feed was contaminated with radionuclides and that the radiation in 
the food travelled south from the affected areas. There was a clear second peak in Cs-37 in the Spring 
of 1987 which the produce from winter fed cattle appeared in the food supply [5,6,10]. 
Given the extremely low mean dose involved in the combined exposure area, UK, Greece and 
Germany (<70 Sv), the increase in infant leukemia was not predicted by the ICRP model. This defines 
an  error  in  the  use  of  a  risk  coefficient  defined  by  the  obstetric  X-ray  data  of  at  minimum  
of 160-fold and an even greater error in the predictive radiation risk model of the ICRP. The ICRP 
model has been criticized for lack of scientific method and for failures to predict or explain a number 
of observations in children [11-13,16]. In particular, it has been argued that the use of acute external 
irradiation data to inform the model for health risks from internal chronic irradiation involved misuse 
of  scientific  method,  and  employed  deductive  rather  than  inductive  reasoning  [9,12,13].  If  these 
criticisms are valid then clearly it is not possible to employ risk factors culled from the Japanese  
A-Bomb  external  high-dose  acute  exposure  series  to  inform  risk  about  chronic  low-dose  internal 
irradiation. And by the same argument, it is not valid to employ the risk factors obtained from the 
external obstetric X-ray data to inform risk models for internal irradiation. It is necessary to employ 
studies of children exposed to internal chronic radiation from fission product isotopes if we wish to 
develop models to predict or explain these same exposures.  Int. J. Environ. Res. Public Health 2009, 6                 
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The nuclear site child leukemia clusters, e.g., Sellafield, Dounreay and La Hague, and others listed 
by ECRR2003 [11] have been extensively studied and confirmed as being real and not due to chance. 
Recently a very large German government-funded study also revealed significant excess leukemia risk 
in children living within 5 km of nuclear sites from 1988–2005 [10]. These children will have been 
exposed to fission-product and uranium releases from the sites; i.e., internal exposures. In all these 
nuclear sites the difference between the yield of childhood leukemia predicted by the ICRP and the 
observed numbers for these nuclear sites is in excess of 300-fold. The existence of the infant leukemias 
reported here for the European cohorts has resulted from doses which are less than those experienced 
by  the  nuclear  site  children,  but  for  whom  there  is  no  alternative  explanation  apart from  internal 
radiation exposure to largely the same fission product isotopes. Further research on infant leukemia in 
this cohort in other countries of Europe might usefully be pursued.  
 
5. Conclusions 
 
The fetal exposures to fallout from the Chernobyl accident in the combined exposed population  
of 2204055 children in Germany, Greece and the United Kingdom resulted in a 43% increase in infant 
leukemia, a disease associated with a gene mutation in utero. The specificity of the cohort defined it as 
one in which exposure to the radioactive fallout from the Chernobyl accident is the only possible cause 
of  the  increased  infant  leukemia  incidence.  Since  the  mean calculated weighted fetal dose to  this 
population  was  0.067  mSv, this  finding defined an error in  the ICRP risk model for this kind of 
exposure and suggests that it is unsafe to predict risks from chronic exposure to internal radionuclides 
on the basis of external doses. Using the best data for external fetal exposures and leukemia, that of the 
Oxford Obstetric X-ray studies of Stewart et al. [18,19] the error in employing such an approach is 
upward of 160-fold. 
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